MaSTherCell to build commercial cell and gene therapy facility in Belgium

MaSTherCell SA signed a lease for a 5,700 m² facility in Gosselies, Belgium, for late-stage and commercial cell and gene therapy manufacturing. The facility is expected to be operational in early 2021 and will create several hundred jobs.

“As a leading CDMO, MaSTherCell has a role to play in solving the current lack of commercial manufacturing capacities in Europe and we believe this facility will be a game changer for market access worldwide.”biospace.com

• 1 source
• biospace.comMaSTherCell SA announces creation of a new commercial manufacturing facility for cell & gene therapies - BioSpaceAnnalee ArmstrongMar 26, 2019

Summarized from public sources; check the original articles before acting on it.